AMGN vs SBUX · P/E 24, rev $10.05B vs P/E 76, rev $37.18B
Amgen Inc (AMGN) versus Starbucks Corporation (SBUX) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Starbucks Corporation (SBUX) is a restaurants company listed on NASDAQ. It is led by Brian R. Niccol.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported SBUX revenue for 2025-09-28 was $37.18B. Net income was $1.86B. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
Not investment advice. Open the AMGN and SBUX stock pages for the full models.
Not investment advice.